SVF Vaccines develops vaccines and immunotherapies to prevent and treat life-threatening diseases based on technology developed at the Karolinska Institute in Stockholm. Current development is focused on a therapeutic vaccine for chronic hepatitis B and D infection, and a prophylactic vaccine targeting both the current COVID-19 pandemic and other coronavirus infections.